Affinity Asset Advisors »

Nls Pharmaceutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSP) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $140k 201k 0.70
2023-06-30 $440k 400k 1.10
2023-03-31 $520k 344k 1.51

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Nls Pharmaceutics

BVF
Bank of America Corporation

View all funds holding Nls Pharmaceutics